- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human interleukin-3 truncated diphtheria toxin f
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human interleukin-3 truncated diphtheria toxin fusion protein
| EU orphan designation number: | EU/3/15/1567
|
| Active ingredient: | Recombinant human interleukin-3 truncated diphtheria toxin fusion protein |
| Indication: | Treatment of blastic plasmacytoid dendritic cell neoplasm |
| Sponsor: | Spector Consulting SAS
41 avenue de la Porte de Villiers, 92200 Neuilly-sur-Seine, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 13/11/2015 | Orphan designation | EMA/OD/064/15 | (2015)8017 of 11/11/2015 |
CONTACT
EU links
Directorate General Health & Consumers